why choose us

First received: May 24, 2023

Clinical Trial: Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid Tumors

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid

Brief Summary: The purpose of this research study is to evaluate the safety, tolerability and activity of VAX014 for intratumoral injections (VAX014) in patients with advanced solid tumors.VAX014 is a targeted oncolytic agent designed to kill tumor cells following intratumoral injection into advanced solid tumors.

Read more